deltatrials
Completed NA INTERVENTIONAL NCT01903733

Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008

AN OPEN-LABEL BOSUTINIB TREATMENT EXTENSION STUDY FOR SUBJECTS WITH CHRONIC MYELOID LEUKEMIA (CML) WHO HAVE PREVIOUSLY PARTICIPATED IN BOSUTINIB STUDIES B1871006 OR B1871008

Sponsor: Pfizer

Conditions Chronic Myeloid Leukemia
Interventions bosutinib
Updated 26 times since 2017 Last updated: Jun 28, 2022 Started: Aug 28, 2013 Primary completion: Jun 5, 2020 Completion: Jun 5, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01903733, this NA trial focuses on Chronic Myeloid Leukemia and remains completed. Sponsored by Pfizer, it has been updated 26 times since 2013, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Mar 2017 · 28 days · monthly snapshot~Mar 2017 – ~Apr 2017 · 31 days · monthly snapshot~Apr 2017 – ~Jun 2017 · 2 months · monthly snapshot~Jun 2017 – ~Sep 2017 · 3 months · monthly snapshot~Sep 2017 – ~Oct 2017 · 30 days · monthly snapshot~Oct 2017 – ~Nov 2017 · 31 days · monthly snapshot~Nov 2017 – ~Dec 2017 · 30 days · monthly snapshot~Dec 2017 – ~Feb 2018 · 2 months · monthly snapshot~Feb 2018 – ~May 2018 · 3 months · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Oct 2018 · 2 months · monthly snapshot~Oct 2018 – ~Nov 2018 · 31 days · monthly snapshot~Nov 2018 – ~Jan 2019 · 2 months · monthly snapshot~Jan 2019 – ~Feb 2019 · 31 days · monthly snapshot~Feb 2019 – ~May 2019 · 3 months · monthly snapshot~May 2019 – ~Jul 2020 · 14 months · monthly snapshot~Jul 2020 – ~Jan 2021 · 6 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Sep 2022 · 12 months · monthly snapshot~Sep 2022 – ~Jul 2024 · 22 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 8 months · monthly snapshot

Change History

26 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Sep 2022 — Jul 2024 [monthly]

    Completed NA

  5. Sep 2021 — Sep 2022 [monthly]

    Completed NA

    Status: Active Not Recruiting → Completed

▶ Show 21 earlier versions

  1. Jan 2021 — Sep 2021 [monthly]

    Active Not Recruiting NA

  2. Jul 2020 — Jan 2021 [monthly]

    Active Not Recruiting NA

  3. May 2019 — Jul 2020 [monthly]

    Active Not Recruiting NA

  4. Feb 2019 — May 2019 [monthly]

    Active Not Recruiting NA

  5. Jan 2019 — Feb 2019 [monthly]

    Active Not Recruiting NA

  6. Nov 2018 — Jan 2019 [monthly]

    Active Not Recruiting NA

  7. Oct 2018 — Nov 2018 [monthly]

    Active Not Recruiting NA

  8. Aug 2018 — Oct 2018 [monthly]

    Active Not Recruiting NA

  9. Jul 2018 — Aug 2018 [monthly]

    Active Not Recruiting NA

  10. Jun 2018 — Jul 2018 [monthly]

    Active Not Recruiting NA

  11. May 2018 — Jun 2018 [monthly]

    Active Not Recruiting NA

    Status: Recruiting → Active Not Recruiting

  12. Feb 2018 — May 2018 [monthly]

    Recruiting NA

  13. Dec 2017 — Feb 2018 [monthly]

    Recruiting NA

  14. Nov 2017 — Dec 2017 [monthly]

    Recruiting NA

  15. Oct 2017 — Nov 2017 [monthly]

    Recruiting NA

  16. Sep 2017 — Oct 2017 [monthly]

    Recruiting NA

  17. Jun 2017 — Sep 2017 [monthly]

    Recruiting NA

  18. Apr 2017 — Jun 2017 [monthly]

    Recruiting NA

  19. Mar 2017 — Apr 2017 [monthly]

    Recruiting NA

    Status: Available → Recruiting

  20. Feb 2017 — Mar 2017 [monthly]

    Available NA

  21. Jan 2017 — Feb 2017 [monthly]

    Available NA

    First recorded

Aug 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Pfizer
Data source: Pfizer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Adelaide, Australia , Akita, Japan , Amsterdam, Netherlands , Ankara, Turkey (Türkiye) , Atlanta, United States , Bangkok, Thailand , Barcelona, Spain , Beijing, China , Bethesda, United States , Bogota, Colombia and 66 more locations